Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism
Open Access
- 1 June 2004
- Vol. 90 (6), 633-637
- https://doi.org/10.1136/hrt.2003.019745
Abstract
Background: To investigate the frequency of cardiac troponin I (cTnI) increases in patients with pulmonary embolism (PE) and to assess the correlation between this finding, the clinical presentation, and outcomes. Methods: Consecutive patients admitted to the coronary care unit with acute PE were prospectively enrolled between January 2000 and December 2001. cTnI was sequentially determined. Various cut off concentrations were analysed, but patients were categorised prospectively as having increased or no increased cTnI based on a cut off concentration of 0.6 ng/ml. The main outcome measure was in-hospital mortality. Results: On admission, 14 of the 48 patients (29%) had cTnI concentrations greater than the receiver operating characteristic curve value used to diagnose acute myocardial infarction (> 0.6 ng/ml). Subsequently, six patients developed increases for an overall prevalence of 42% (20 of 42). The prevalence was higher when lower cut off concentrations were used: 73% (35 of 48) at the 99th centile and 60% (29 of 48) at the 10% coefficient of variability. Increased cTnI > 0.6 ng/ml was associated with a slower oxygen saturation (86 (7)% v 93 (4)%, p < 0.0001) and more frequent involvement of the main pulmonary arteries as assessed by spiral computed tomography (100% v 60%, p = 0.022). In-hospital mortality was 36% (5 of 14) of patients with increases > 0.6 ng/ml v 3% (1 of 42) of patients with lower concentrations (p = 0.008). Increased cTnI > 0.6 ng/ml on admission was the most powerful predictor of mortality (p = 0.046). Conclusions: In high risk patients with acute PE, cTnI was frequently detected on admission. It was the strongest independent predictor of mortality.Keywords
This publication has 18 references indexed in Scilit:
- European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trialsAmerican Heart Journal, 2002
- Importance of Cardiac Troponins I and T in Risk Stratification of Patients With Acute Pulmonary EmbolismCirculation, 2002
- Release Kinetics of Cardiac Troponin T in Survivors of Confirmed Severe Pulmonary EmbolismClinical Chemistry, 2002
- Elevations in Cardiac Troponin Measurements: False False-Positives: The Real TruthCardiovascular Toxicology, 2001
- Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromesAmerican Heart Journal, 2000
- Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunctionJournal of the American College of Cardiology, 2000
- Guidelines on diagnosis and management of acute pulmonary embolismEuropean Heart Journal, 2000
- Independent Prognostic Value of Cardiac Troponin T in Patients With Confirmed Pulmonary EmbolismCirculation, 2000
- Right ventricular dysfunction after acute pulmonary embolism: Pathophysiologic factors, detection, and therapeutic implicationsAmerican Heart Journal, 1995
- CLINICAL FEATURES OF PULMONARY EMBOLISMThe Lancet, 1961